BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37809070)

  • 1. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.
    Chear CT; Ismail IH; Chan KC; Noh LM; Kassim A; Latiff AHA; Gill SS; Ramly NH; Tan KK; Sundaraj C; Choo CM; Mohamed SAS; Baharin MF; Zamri AS; Yahya SNHS; Mohamad SB; Ripen AM
    Front Immunol; 2023; 14():1252765. PubMed ID: 37809070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
    Gao S; Hu S; Duan H; Wang L; Kong X
    BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 4. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia.
    Zhou Q; Teng Y; Pan J; Shi Q; Liu Y; Zhang F; Liang D; Li Z; Wu L
    Clin Chim Acta; 2022 Jun; 531():48-55. PubMed ID: 35245483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
    J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients.
    Qin X; Jiang LP; Tang XM; Wang M; Liu EM; Zhao XD
    World J Pediatr; 2013 Aug; 9(3):273-7. PubMed ID: 23335184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
    Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
    Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
    Kong X; Mo G; Liu N; Tian P; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.
    Tóth B; Volokha A; Mihas A; Pac M; Bernatowska E; Kondratenko I; Polyakov A; Erdos M; Pasic S; Bataneant M; Szaflarska A; Mironska K; Richter D; Stavrik K; Avcin T; Márton G; Nagy K; Dérfalvi B; Szolnoky M; Kalmár A; Belevtsev M; Guseva M; Rugina A; Kriván G; Timár L; Nyul Z; Mosdósi B; Kareva L; Peova S; Chernyshova L; Gherghina I; Serban M; Conley ME; Notarangelo LD; Smith CI; van Dongen J; van der Burg M; Maródi L
    Mol Immunol; 2009 Jun; 46(10):2140-6. PubMed ID: 19419768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK; Curtis SK; Vogler LB; Vihinen M
    Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.
    Rivière JG; Franco-Jarava C; Martínez-Gallo M; Aguiló-Cucurull A; Blasco-Pérez L; Paramonov I; Antolín M; Martín-Nalda A; Soler-Palacín P; Colobran R
    Front Immunol; 2020; 11():46. PubMed ID: 32117230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey: Novel mutations in BTK gene.
    Doğruel D; Serbes M; Şaşihüseyinoğlu AŞ; Yılmaz M; Altıntaş DU; Bişgin A
    Allergol Immunopathol (Madr); 2019; 47(1):24-31. PubMed ID: 30072168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
    Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
    Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical X-linked agammaglobulinemia diagnosed in three adults.
    Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
    Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.